Nicholas Investment Partners, LP - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is and the CUSIP is 803607AB6. A total of 44 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Nicholas Investment Partners, LP ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$1,977,000
+85.3%
1,500,000
+222.6%
0.12%
-42.9%
Q2 2020$1,067,000
-64.0%
465,000
-76.2%
0.22%
-62.3%
Q1 2020$2,960,000
-22.0%
1,950,0000.0%0.58%
+47.3%
Q4 2019$3,793,000
+52.7%
1,950,000
+3.7%
0.39%
+87.1%
Q3 2019$2,484,000
+132.6%
1,880,000
+291.7%
0.21%
+113.3%
Q2 2019$1,068,000
+23.3%
480,0000.0%0.10%
+27.3%
Q1 2019$866,000480,0000.08%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 88,657,000$148,264,0002.95%
DeepCurrents Investment Group LLC 45,997,000$76,672,0002.94%
TENOR CAPITAL MANAGEMENT Co., L.P. 38,394,000$64,158,0001.47%
WOLVERINE ASSET MANAGEMENT LLC 71,012,000$118,356,0001.28%
Opti Capital Management, LP 3,000,000$5,013,0000.46%
MIZUHO SECURITIES USA LLC 1,663,000$2,766,0000.38%
Verition Fund Management LLC 25,954,000$21,680,6590.24%
Aequim Alternative Investments LP 5,000,000$8,345,0000.24%
PALISADE CAPITAL MANAGEMENT, LP 3,831,000$6,522,0000.18%
LORD, ABBETT & CO. LLC 23,424,000$39,095,0000.14%
View complete list of SAREPTA THERAPEUTICS INC shareholders